226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
510.13%
Some net income increase while BABA is negative at -51.26%. John Neff would see a short-term edge over the struggling competitor.
9.57%
D&A growth well above BABA's 4.72%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
401.59%
Deferred tax of 401.59% while BABA is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
11.40%
SBC growth well above BABA's 7.40%. Michael Burry would flag major dilution risk vs. competitor’s approach.
331.14%
Working capital change of 331.14% while BABA is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
-100.34%
AR is negative yoy while BABA is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
12.62%
Inventory growth of 12.62% while BABA is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
202.46%
AP growth of 202.46% while BABA is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
121.54%
Growth of 121.54% while BABA is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-52.25%
Both negative yoy, with BABA at -82.65%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
237.62%
Some CFO growth while BABA is negative at -70.29%. John Neff would note a short-term liquidity lead over the competitor.
-9.54%
Negative yoy CapEx while BABA is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-201.90%
Negative yoy acquisition while BABA stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-21.12%
Negative yoy purchasing while BABA stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
8.61%
Liquidation growth of 8.61% while BABA is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-190.91%
Both yoy lines negative, with BABA at -17.75%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-34.35%
Both yoy lines negative, with BABA at -17.75%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-96.97%
We cut debt repayment yoy while BABA is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.